nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—head and neck cancer—Graves' disease	0.846	1	CtDrD
Docetaxel—Drug fever—Methimazole—Graves' disease	0.00739	0.104	CcSEcCtD
Docetaxel—Drug fever—Propylthiouracil—Graves' disease	0.00628	0.0887	CcSEcCtD
Docetaxel—Interstitial pneumonia—Propylthiouracil—Graves' disease	0.00434	0.0613	CcSEcCtD
Docetaxel—GHRHR—pituitary gland—Graves' disease	0.00357	0.0625	CbGeAlD
Docetaxel—Neuritis—Methimazole—Graves' disease	0.0033	0.0466	CcSEcCtD
Docetaxel—Ageusia—Methimazole—Graves' disease	0.00304	0.043	CcSEcCtD
Docetaxel—Interstitial lung disease—Propylthiouracil—Graves' disease	0.00296	0.0418	CcSEcCtD
Docetaxel—Neuritis—Propylthiouracil—Graves' disease	0.00281	0.0397	CcSEcCtD
Docetaxel—Ageusia—Propylthiouracil—Graves' disease	0.00259	0.0365	CcSEcCtD
Docetaxel—MAP4—eye—Graves' disease	0.00188	0.033	CbGeAlD
Docetaxel—MAP4—connective tissue—Graves' disease	0.00181	0.0318	CbGeAlD
Docetaxel—TUBB3—connective tissue—Graves' disease	0.00181	0.0318	CbGeAlD
Docetaxel—MAPT—pituitary gland—Graves' disease	0.00178	0.0312	CbGeAlD
Docetaxel—MAPT—adipose tissue—Graves' disease	0.00177	0.031	CbGeAlD
Docetaxel—Hepatic failure—Propylthiouracil—Graves' disease	0.00169	0.0239	CcSEcCtD
Docetaxel—BCL2—connective tissue—Graves' disease	0.00165	0.0289	CbGeAlD
Docetaxel—MAPT—thyroid gland—Graves' disease	0.00153	0.0269	CbGeAlD
Docetaxel—MAP2—eye—Graves' disease	0.00148	0.026	CbGeAlD
Docetaxel—MAP4—adipose tissue—Graves' disease	0.00139	0.0244	CbGeAlD
Docetaxel—TUBB1—adipose tissue—Graves' disease	0.00136	0.0239	CbGeAlD
Docetaxel—Neuropathy peripheral—Methimazole—Graves' disease	0.00135	0.0191	CcSEcCtD
Docetaxel—Jaundice—Methimazole—Graves' disease	0.00134	0.019	CcSEcCtD
Docetaxel—Agranulocytosis—Methimazole—Graves' disease	0.00129	0.0182	CcSEcCtD
Docetaxel—EGFR—adipose tissue—Graves' disease	0.00125	0.0219	CbGeAlD
Docetaxel—Hepatitis—Methimazole—Graves' disease	0.00124	0.0175	CcSEcCtD
Docetaxel—SLCO1B3—pituitary gland—Graves' disease	0.00122	0.0214	CbGeAlD
Docetaxel—MAP4—thyroid gland—Graves' disease	0.0012	0.0211	CbGeAlD
Docetaxel—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.00115	0.0162	CcSEcCtD
Docetaxel—TUBB4A—eye—Graves' disease	0.00115	0.0201	CbGeAlD
Docetaxel—Jaundice—Propylthiouracil—Graves' disease	0.00114	0.0161	CcSEcCtD
Docetaxel—TUBB2B—eye—Graves' disease	0.00111	0.0194	CbGeAlD
Docetaxel—TUBB4A—connective tissue—Graves' disease	0.0011	0.0194	CbGeAlD
Docetaxel—MAP2—pituitary gland—Graves' disease	0.0011	0.0193	CbGeAlD
Docetaxel—MAP2—adipose tissue—Graves' disease	0.0011	0.0192	CbGeAlD
Docetaxel—BCL2—thyroid gland—Graves' disease	0.0011	0.0192	CbGeAlD
Docetaxel—Agranulocytosis—Propylthiouracil—Graves' disease	0.00109	0.0155	CcSEcCtD
Docetaxel—Alopecia—Methimazole—Graves' disease	0.00109	0.0154	CcSEcCtD
Docetaxel—EGFR—thyroid gland—Graves' disease	0.00108	0.019	CbGeAlD
Docetaxel—TUBB2B—connective tissue—Graves' disease	0.00107	0.0187	CbGeAlD
Docetaxel—Haemoglobin—Propylthiouracil—Graves' disease	0.00106	0.0149	CcSEcCtD
Docetaxel—Hepatitis—Propylthiouracil—Graves' disease	0.00105	0.0149	CcSEcCtD
Docetaxel—Haemorrhage—Propylthiouracil—Graves' disease	0.00105	0.0149	CcSEcCtD
Docetaxel—TUBB2A—eye—Graves' disease	0.00104	0.0183	CbGeAlD
Docetaxel—TUBB2A—connective tissue—Graves' disease	0.001	0.0176	CbGeAlD
Docetaxel—Leukopenia—Methimazole—Graves' disease	0.000965	0.0136	CcSEcCtD
Docetaxel—MAP2—thyroid gland—Graves' disease	0.000949	0.0166	CbGeAlD
Docetaxel—Alopecia—Propylthiouracil—Graves' disease	0.00093	0.0131	CcSEcCtD
Docetaxel—Arthralgia—Methimazole—Graves' disease	0.000917	0.013	CcSEcCtD
Docetaxel—Myalgia—Methimazole—Graves' disease	0.000917	0.013	CcSEcCtD
Docetaxel—Dysgeusia—Propylthiouracil—Graves' disease	0.000897	0.0127	CcSEcCtD
Docetaxel—TUBB4B—eye—Graves' disease	0.000894	0.0157	CbGeAlD
Docetaxel—Oedema—Methimazole—Graves' disease	0.00088	0.0124	CcSEcCtD
Docetaxel—Thrombocytopenia—Methimazole—Graves' disease	0.000861	0.0122	CcSEcCtD
Docetaxel—TUBB4B—connective tissue—Graves' disease	0.000861	0.0151	CbGeAlD
Docetaxel—TUBB2B—pituitary gland—Graves' disease	0.000822	0.0144	CbGeAlD
Docetaxel—Leukopenia—Propylthiouracil—Graves' disease	0.00082	0.0116	CcSEcCtD
Docetaxel—TUBB2B—adipose tissue—Graves' disease	0.000819	0.0144	CbGeAlD
Docetaxel—Musculoskeletal discomfort—Methimazole—Graves' disease	0.000801	0.0113	CcSEcCtD
Docetaxel—Paraesthesia—Methimazole—Graves' disease	0.00079	0.0112	CcSEcCtD
Docetaxel—Somnolence—Methimazole—Graves' disease	0.000782	0.011	CcSEcCtD
Docetaxel—Myalgia—Propylthiouracil—Graves' disease	0.00078	0.011	CcSEcCtD
Docetaxel—Arthralgia—Propylthiouracil—Graves' disease	0.00078	0.011	CcSEcCtD
Docetaxel—TUBB—pituitary gland—Graves' disease	0.000778	0.0136	CbGeAlD
Docetaxel—TUBB—adipose tissue—Graves' disease	0.000775	0.0136	CbGeAlD
Docetaxel—Dyspepsia—Methimazole—Graves' disease	0.000774	0.0109	CcSEcCtD
Docetaxel—TUBB2A—pituitary gland—Graves' disease	0.000774	0.0136	CbGeAlD
Docetaxel—TUBB2A—adipose tissue—Graves' disease	0.000771	0.0135	CbGeAlD
Docetaxel—GHRHR—G alpha (s) signalling events—TSHR—Graves' disease	0.000764	0.0296	CbGpPWpGaD
Docetaxel—TUBB6—pituitary gland—Graves' disease	0.000763	0.0134	CbGeAlD
Docetaxel—TUBB6—adipose tissue—Graves' disease	0.00076	0.0133	CbGeAlD
Docetaxel—Oedema—Propylthiouracil—Graves' disease	0.000748	0.0106	CcSEcCtD
Docetaxel—TUBB4A—thyroid gland—Graves' disease	0.000733	0.0129	CbGeAlD
Docetaxel—Thrombocytopenia—Propylthiouracil—Graves' disease	0.000732	0.0103	CcSEcCtD
Docetaxel—TUBB2B—thyroid gland—Graves' disease	0.000709	0.0124	CbGeAlD
Docetaxel—CYP1B1—eye—Graves' disease	0.000708	0.0124	CbGeAlD
Docetaxel—Body temperature increased—Methimazole—Graves' disease	0.000695	0.00982	CcSEcCtD
Docetaxel—CYP1B1—connective tissue—Graves' disease	0.000682	0.012	CbGeAlD
Docetaxel—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.000681	0.00962	CcSEcCtD
Docetaxel—Paraesthesia—Propylthiouracil—Graves' disease	0.000672	0.00948	CcSEcCtD
Docetaxel—TUBB—thyroid gland—Graves' disease	0.00067	0.0118	CbGeAlD
Docetaxel—ABCC10—pituitary gland—Graves' disease	0.000668	0.0117	CbGeAlD
Docetaxel—TUBB2A—thyroid gland—Graves' disease	0.000667	0.0117	CbGeAlD
Docetaxel—ABCC10—adipose tissue—Graves' disease	0.000665	0.0117	CbGeAlD
Docetaxel—Somnolence—Propylthiouracil—Graves' disease	0.000665	0.00939	CcSEcCtD
Docetaxel—TUBB4B—pituitary gland—Graves' disease	0.000663	0.0116	CbGeAlD
Docetaxel—TUBB4B—adipose tissue—Graves' disease	0.000661	0.0116	CbGeAlD
Docetaxel—Dyspepsia—Propylthiouracil—Graves' disease	0.000658	0.0093	CcSEcCtD
Docetaxel—TUBB6—thyroid gland—Graves' disease	0.000658	0.0115	CbGeAlD
Docetaxel—Pruritus—Methimazole—Graves' disease	0.000622	0.00879	CcSEcCtD
Docetaxel—KIF11—MHC class II antigen presentation—HLA-DQB1—Graves' disease	0.000617	0.0239	CbGpPWpGaD
Docetaxel—Body temperature increased—Propylthiouracil—Graves' disease	0.000591	0.00835	CcSEcCtD
Docetaxel—ABCC10—thyroid gland—Graves' disease	0.000576	0.0101	CbGeAlD
Docetaxel—TUBB4B—thyroid gland—Graves' disease	0.000572	0.01	CbGeAlD
Docetaxel—Vomiting—Methimazole—Graves' disease	0.000559	0.0079	CcSEcCtD
Docetaxel—BCL2—Apoptosis—TNFRSF25—Graves' disease	0.000558	0.0216	CbGpPWpGaD
Docetaxel—Rash—Methimazole—Graves' disease	0.000555	0.00783	CcSEcCtD
Docetaxel—Dermatitis—Methimazole—Graves' disease	0.000554	0.00782	CcSEcCtD
Docetaxel—Headache—Methimazole—Graves' disease	0.000551	0.00778	CcSEcCtD
Docetaxel—Pruritus—Propylthiouracil—Graves' disease	0.000529	0.00747	CcSEcCtD
Docetaxel—CYP1B1—pituitary gland—Graves' disease	0.000525	0.00921	CbGeAlD
Docetaxel—BCL2—Apoptosis Modulation and Signaling—TNFRSF25—Graves' disease	0.000524	0.0203	CbGpPWpGaD
Docetaxel—CYP1B1—adipose tissue—Graves' disease	0.000523	0.00917	CbGeAlD
Docetaxel—TUBB6—Orphan transporters—GABRA3—Graves' disease	0.000523	0.0203	CbGpPWpGaD
Docetaxel—TUBB2B—Orphan transporters—GABRA3—Graves' disease	0.000523	0.0203	CbGpPWpGaD
Docetaxel—Nausea—Methimazole—Graves' disease	0.000522	0.00738	CcSEcCtD
Docetaxel—TUBB3—Orphan transporters—GABRA3—Graves' disease	0.000505	0.0196	CbGpPWpGaD
Docetaxel—TUBB2A—Orphan transporters—GABRA3—Graves' disease	0.000489	0.019	CbGpPWpGaD
Docetaxel—TUBB1—Orphan transporters—GABRA3—Graves' disease	0.000478	0.0185	CbGpPWpGaD
Docetaxel—Vomiting—Propylthiouracil—Graves' disease	0.000475	0.00672	CcSEcCtD
Docetaxel—ABCC1—pituitary gland—Graves' disease	0.000473	0.00828	CbGeAlD
Docetaxel—Rash—Propylthiouracil—Graves' disease	0.000472	0.00666	CcSEcCtD
Docetaxel—Dermatitis—Propylthiouracil—Graves' disease	0.000471	0.00665	CcSEcCtD
Docetaxel—ABCC1—adipose tissue—Graves' disease	0.000471	0.00825	CbGeAlD
Docetaxel—KIF11—MHC class II antigen presentation—HLA-DRB1—Graves' disease	0.000469	0.0182	CbGpPWpGaD
Docetaxel—Headache—Propylthiouracil—Graves' disease	0.000468	0.00662	CcSEcCtD
Docetaxel—CYP1B1—thyroid gland—Graves' disease	0.000453	0.00794	CbGeAlD
Docetaxel—MAPT—IL-2 Signaling Pathway—IL2RA—Graves' disease	0.000448	0.0174	CbGpPWpGaD
Docetaxel—Nausea—Propylthiouracil—Graves' disease	0.000444	0.00627	CcSEcCtD
Docetaxel—TUBB4A—Orphan transporters—GABRA3—Graves' disease	0.00043	0.0166	CbGpPWpGaD
Docetaxel—ABCC1—thyroid gland—Graves' disease	0.000407	0.00714	CbGeAlD
Docetaxel—TUBB4B—Orphan transporters—GABRA3—Graves' disease	0.000393	0.0152	CbGpPWpGaD
Docetaxel—ABCG2—pituitary gland—Graves' disease	0.000391	0.00686	CbGeAlD
Docetaxel—ABCG2—adipose tissue—Graves' disease	0.00039	0.00683	CbGeAlD
Docetaxel—EGFR—Arf6 signaling events—TSHR—Graves' disease	0.000382	0.0148	CbGpPWpGaD
Docetaxel—BCL2—IL2 signaling events mediated by STAT5—FASLG—Graves' disease	0.000376	0.0146	CbGpPWpGaD
Docetaxel—CYP3A5—adipose tissue—Graves' disease	0.000362	0.00634	CbGeAlD
Docetaxel—BCL2—IL2 signaling events mediated by STAT5—IL2RA—Graves' disease	0.000361	0.014	CbGpPWpGaD
Docetaxel—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—FASLG—Graves' disease	0.000349	0.0135	CbGpPWpGaD
Docetaxel—ABCG2—thyroid gland—Graves' disease	0.000337	0.00591	CbGeAlD
Docetaxel—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—FAS—Graves' disease	0.000336	0.013	CbGpPWpGaD
Docetaxel—BCL2—IL2 signaling events mediated by PI3K—IL2RA—Graves' disease	0.000305	0.0118	CbGpPWpGaD
Docetaxel—BCL2—FAS pathway and Stress induction of HSP regulation—FASLG—Graves' disease	0.000288	0.0111	CbGpPWpGaD
Docetaxel—GHRHR—GPCR ligand binding—TSHR—Graves' disease	0.000277	0.0108	CbGpPWpGaD
Docetaxel—BCL2—FAS pathway and Stress induction of HSP regulation—FAS—Graves' disease	0.000277	0.0107	CbGpPWpGaD
Docetaxel—BCL2—IL-2 Signaling Pathway—IL2RA—Graves' disease	0.000276	0.0107	CbGpPWpGaD
Docetaxel—MAPT—Alzheimers Disease—FAS—Graves' disease	0.000272	0.0105	CbGpPWpGaD
Docetaxel—BCL2—Interleukin-11 Signaling Pathway—ICAM1—Graves' disease	0.00023	0.00892	CbGpPWpGaD
Docetaxel—BCL2—IL2-mediated signaling events—IL2RA—Graves' disease	0.000225	0.00874	CbGpPWpGaD
Docetaxel—BCL2—Caspase Cascade in Apoptosis—FASLG—Graves' disease	0.000225	0.00873	CbGpPWpGaD
Docetaxel—BCL2—Overview of nanoparticle effects—TNF—Graves' disease	0.000222	0.0086	CbGpPWpGaD
Docetaxel—BCL2—Caspase Cascade in Apoptosis—FAS—Graves' disease	0.000217	0.00842	CbGpPWpGaD
Docetaxel—ABCC10—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000202	0.00782	CbGpPWpGaD
Docetaxel—ABCB1—pituitary gland—Graves' disease	0.000193	0.00338	CbGeAlD
Docetaxel—ABCB1—adipose tissue—Graves' disease	0.000192	0.00337	CbGeAlD
Docetaxel—KIF11—Adaptive Immune System—HLA-E—Graves' disease	0.000187	0.00723	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—CD40—Graves' disease	0.000182	0.00707	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—CTLA4—Graves' disease	0.00018	0.00696	CbGpPWpGaD
Docetaxel—GHRHR—GPCR ligand binding—CXCL10—Graves' disease	0.000179	0.00695	CbGpPWpGaD
Docetaxel—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TNF—Graves' disease	0.000173	0.0067	CbGpPWpGaD
Docetaxel—ABCB1—thyroid gland—Graves' disease	0.000166	0.00292	CbGeAlD
Docetaxel—BCL2—Apoptosis—FASLG—Graves' disease	0.000165	0.0064	CbGpPWpGaD
Docetaxel—MAP2—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000165	0.00638	CbGpPWpGaD
Docetaxel—MAPT—Apoptosis—FASLG—Graves' disease	0.000165	0.00638	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—FAS—Graves' disease	0.000159	0.00617	CbGpPWpGaD
Docetaxel—MAPT—Alzheimers Disease—IL1B—Graves' disease	0.000159	0.00617	CbGpPWpGaD
Docetaxel—MAPT—Apoptosis—FAS—Graves' disease	0.000159	0.00615	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—TSHR—Graves' disease	0.000157	0.00608	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis Modulation and Signaling—FASLG—Graves' disease	0.000155	0.006	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—FASLG—Graves' disease	0.000154	0.00598	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis Modulation and Signaling—FAS—Graves' disease	0.000149	0.00579	CbGpPWpGaD
Docetaxel—BCL2—IL2-mediated signaling events—IFNG—Graves' disease	0.000149	0.00576	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—FAS—Graves' disease	0.000149	0.00576	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000148	0.00574	CbGpPWpGaD
Docetaxel—KIF11—Hemostasis—IL2RA—Graves' disease	0.000144	0.00558	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IFIH1—Graves' disease	0.000144	0.00557	CbGpPWpGaD
Docetaxel—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—Graves' disease	0.000143	0.00553	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—TSHR—Graves' disease	0.000142	0.00552	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000139	0.00539	CbGpPWpGaD
Docetaxel—BCL2—ATF-2 transcription factor network—IFNG—Graves' disease	0.000139	0.00537	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—CD8A—Graves' disease	0.000138	0.00536	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000134	0.0052	CbGpPWpGaD
Docetaxel—BCL2—DNA Damage Response (only ATM dependent)—FASLG—Graves' disease	0.000134	0.0052	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—HLA-B—Graves' disease	0.000133	0.00515	CbGpPWpGaD
Docetaxel—TUBB6—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000128	0.00495	CbGpPWpGaD
Docetaxel—TUBB2B—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000128	0.00495	CbGpPWpGaD
Docetaxel—BCL2—Amyotrophic lateral sclerosis (ALS)—TNF—Graves' disease	0.000128	0.00494	CbGpPWpGaD
Docetaxel—EGFR—SHP2 signaling—IL2RA—Graves' disease	0.000126	0.00488	CbGpPWpGaD
Docetaxel—TUBB3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000123	0.00478	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—HLA-A—Graves' disease	0.000123	0.00477	CbGpPWpGaD
Docetaxel—MAP2—SIDS Susceptibility Pathways—TNF—Graves' disease	0.00012	0.00463	CbGpPWpGaD
Docetaxel—TUBB2A—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000119	0.00463	CbGpPWpGaD
Docetaxel—BCL2—FAS pathway and Stress induction of HSP regulation—TNF—Graves' disease	0.000118	0.00456	CbGpPWpGaD
Docetaxel—TUBB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000117	0.00453	CbGpPWpGaD
Docetaxel—MAPT—Alzheimers Disease—TNF—Graves' disease	0.000115	0.00448	CbGpPWpGaD
Docetaxel—KIF11—Immune System—HLA-E—Graves' disease	0.000113	0.00439	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000113	0.00436	CbGpPWpGaD
Docetaxel—EGFR—Thromboxane A2 receptor signaling—ICAM1—Graves' disease	0.000112	0.00435	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CD40—Graves' disease	0.000111	0.00429	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CTLA4—Graves' disease	0.000109	0.00422	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—ICAM1—Graves' disease	0.000108	0.00419	CbGpPWpGaD
Docetaxel—BCL2—Direct p53 effectors—FAS—Graves' disease	0.000106	0.0041	CbGpPWpGaD
Docetaxel—BCL2—Ceramide signaling pathway—TNF—Graves' disease	0.000106	0.0041	CbGpPWpGaD
Docetaxel—TUBB4A—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000105	0.00406	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	0.000103	0.00398	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—CXCL10—Graves' disease	0.000101	0.00393	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—FASLG—Graves' disease	0.000101	0.00392	CbGpPWpGaD
Docetaxel—BCL2—C-MYB transcription factor network—CD4—Graves' disease	0.000101	0.00391	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	0.0001	0.00387	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—GC—Graves' disease	9.8e-05	0.0038	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—FAS—Graves' disease	9.76e-05	0.00378	CbGpPWpGaD
Docetaxel—TUBB4B—Transmembrane transport of small molecules—GABRA3—Graves' disease	9.59e-05	0.00372	CbGpPWpGaD
Docetaxel—TUBB2B—Metabolism of proteins—B3GNT2—Graves' disease	9.46e-05	0.00367	CbGpPWpGaD
Docetaxel—TUBB6—Metabolism of proteins—B3GNT2—Graves' disease	9.46e-05	0.00367	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—CXCL10—Graves' disease	9.33e-05	0.00362	CbGpPWpGaD
Docetaxel—BCL2—Caspase Cascade in Apoptosis—TNF—Graves' disease	9.22e-05	0.00357	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—CXCL10—Graves' disease	9.2e-05	0.00357	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL1B—Graves' disease	9.15e-05	0.00355	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—B3GNT2—Graves' disease	9.14e-05	0.00354	CbGpPWpGaD
Docetaxel—SLC22A7—Transmembrane transport of small molecules—GABRA3—Graves' disease	9.12e-05	0.00354	CbGpPWpGaD
Docetaxel—KIF11—Immune System—HLA-DQB1—Graves' disease	8.98e-05	0.00348	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor Pathway—IL1B—Graves' disease	8.92e-05	0.00346	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—B3GNT2—Graves' disease	8.85e-05	0.00343	CbGpPWpGaD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—IFNG—Graves' disease	8.74e-05	0.00339	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—IL1B—Graves' disease	8.7e-05	0.00337	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—GABRA3—Graves' disease	8.67e-05	0.00336	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—B3GNT2—Graves' disease	8.65e-05	0.00335	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	8.56e-05	0.00332	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TSHR—Graves' disease	8.41e-05	0.00326	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CD8A—Graves' disease	8.38e-05	0.00325	CbGpPWpGaD
Docetaxel—EGFR—SHP2 signaling—IFNG—Graves' disease	8.31e-05	0.00322	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	8.25e-05	0.0032	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—HLA-E—Graves' disease	8.21e-05	0.00318	CbGpPWpGaD
Docetaxel—KIF11—Immune System—HLA-B—Graves' disease	8.06e-05	0.00312	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—CD4—Graves' disease	7.94e-05	0.00308	CbGpPWpGaD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—IL1B—Graves' disease	7.79e-05	0.00302	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—B3GNT2—Graves' disease	7.77e-05	0.00301	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—IL2RA—Graves' disease	7.74e-05	0.003	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—HLA-E—Graves' disease	7.72e-05	0.00299	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IL2RA—Graves' disease	7.56e-05	0.00293	CbGpPWpGaD
Docetaxel—KIF11—Immune System—HLA-A—Graves' disease	7.47e-05	0.0029	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—HLA-E—Graves' disease	7.43e-05	0.00288	CbGpPWpGaD
Docetaxel—EGFR—Regulation of Telomerase—IFNG—Graves' disease	7.31e-05	0.00283	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—CD40—Graves' disease	7.26e-05	0.00282	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—CTLA4—Graves' disease	7.16e-05	0.00277	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—B3GNT2—Graves' disease	7.11e-05	0.00275	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—IL2RA—Graves' disease	7.03e-05	0.00272	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—GC—Graves' disease	6.93e-05	0.00269	CbGpPWpGaD
Docetaxel—KIF11—Immune System—HLA-DRB1—Graves' disease	6.83e-05	0.00265	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TNF—Graves' disease	6.76e-05	0.00262	CbGpPWpGaD
Docetaxel—MAPT—Apoptosis—TNF—Graves' disease	6.74e-05	0.00261	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—GC—Graves' disease	6.7e-05	0.0026	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	6.64e-05	0.00257	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor—TNF—Graves' disease	6.64e-05	0.00257	CbGpPWpGaD
Docetaxel—KIF11—Immune System—ICAM1—Graves' disease	6.55e-05	0.00254	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor—TNF—Graves' disease	6.47e-05	0.00251	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	6.47e-05	0.00251	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—IFIH1—Graves' disease	6.45e-05	0.0025	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—TNF—Graves' disease	6.32e-05	0.00245	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—FAS—Graves' disease	6.26e-05	0.00242	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—GABRA3—Graves' disease	6.2e-05	0.0024	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—ICAM1—Graves' disease	6.18e-05	0.0024	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—GABRA3—Graves' disease	6.13e-05	0.00237	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—HLA-DQB1—Graves' disease	5.9e-05	0.00228	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	5.7e-05	0.00221	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—FASLG—Graves' disease	5.61e-05	0.00217	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—HLA-B—Graves' disease	5.5e-05	0.00213	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CXCL10—Graves' disease	5.43e-05	0.00211	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—FAS—Graves' disease	5.41e-05	0.0021	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—GABRA3—Graves' disease	5.39e-05	0.00209	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—HLA-B—Graves' disease	5.3e-05	0.00205	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—FASLG—Graves' disease	5.18e-05	0.00201	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—HLA-E—Graves' disease	5.08e-05	0.00197	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	5.06e-05	0.00196	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—FAS—Graves' disease	4.99e-05	0.00193	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IFNG—Graves' disease	4.99e-05	0.00193	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—IL2RA—Graves' disease	4.96e-05	0.00192	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—HLA-A—Graves' disease	4.91e-05	0.0019	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	4.88e-05	0.00189	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CD4—Graves' disease	4.81e-05	0.00187	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—IFNG—Graves' disease	4.71e-05	0.00182	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—HLA-DRB1—Graves' disease	4.48e-05	0.00174	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IL1B—Graves' disease	4.45e-05	0.00172	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—GC—Graves' disease	4.37e-05	0.00169	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—IL1B—Graves' disease	4.2e-05	0.00163	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—IL2RA—Graves' disease	4.15e-05	0.00161	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TNF—Graves' disease	4.14e-05	0.00161	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IFIH1—Graves' disease	3.81e-05	0.00148	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IFIH1—Graves' disease	3.76e-05	0.00146	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—HLA-B—Graves' disease	3.62e-05	0.0014	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	3.5e-05	0.00136	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—B3GNT2—Graves' disease	3.31e-05	0.00128	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—IFNG—Graves' disease	3.27e-05	0.00127	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—IL1B—Graves' disease	3.16e-05	0.00123	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GC—Graves' disease	3.09e-05	0.0012	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—TNF—Graves' disease	3.05e-05	0.00118	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HLA-E—Graves' disease	3e-05	0.00116	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GC—Graves' disease	2.99e-05	0.00116	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HLA-E—Graves' disease	2.96e-05	0.00115	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—IL1B—Graves' disease	2.92e-05	0.00113	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	2.91e-05	0.00113	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD40—Graves' disease	2.89e-05	0.00112	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HLA-E—Graves' disease	2.88e-05	0.00112	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CTLA4—Graves' disease	2.85e-05	0.0011	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD40—Graves' disease	2.82e-05	0.00109	CbGpPWpGaD
Docetaxel—ABCC1—Disease—B3GNT2—Graves' disease	2.79e-05	0.00108	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CTLA4—Graves' disease	2.78e-05	0.00108	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GC—Graves' disease	2.72e-05	0.00105	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GC—Graves' disease	2.69e-05	0.00104	CbGpPWpGaD
Docetaxel—EGFR—Disease—B3GNT2—Graves' disease	2.63e-05	0.00102	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—TSHR—Graves' disease	2.59e-05	0.001	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	2.55e-05	0.00099	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	2.46e-05	0.000955	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HLA-DQB1—Graves' disease	2.35e-05	0.000909	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—B3GNT2—Graves' disease	2.34e-05	0.000907	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TNF—Graves' disease	2.3e-05	0.00089	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HLA-DQB1—Graves' disease	2.29e-05	0.000886	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—B3GNT2—Graves' disease	2.26e-05	0.000877	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IFIH1—Graves' disease	2.22e-05	0.000861	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD8A—Graves' disease	2.19e-05	0.000849	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CD4—Graves' disease	2.16e-05	0.000837	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HLA-B—Graves' disease	2.14e-05	0.000829	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD8A—Graves' disease	2.13e-05	0.000827	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—TNF—Graves' disease	2.12e-05	0.000821	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HLA-B—Graves' disease	2.11e-05	0.000816	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	2.07e-05	0.000803	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—B3GNT2—Graves' disease	2.06e-05	0.000798	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HLA-B—Graves' disease	2.05e-05	0.000796	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—B3GNT2—Graves' disease	2.04e-05	0.000791	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL2RA—Graves' disease	1.97e-05	0.000765	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HLA-A—Graves' disease	1.95e-05	0.000756	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GC—Graves' disease	1.95e-05	0.000754	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HLA-A—Graves' disease	1.9e-05	0.000737	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HLA-DRB1—Graves' disease	1.78e-05	0.000691	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-E—Graves' disease	1.75e-05	0.000677	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HLA-DRB1—Graves' disease	1.74e-05	0.000674	CbGpPWpGaD
Docetaxel—BCL2—Immune System—ICAM1—Graves' disease	1.71e-05	0.000663	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD40—Graves' disease	1.71e-05	0.000662	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CTLA4—Graves' disease	1.68e-05	0.000652	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCL10—Graves' disease	1.67e-05	0.000648	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—ICAM1—Graves' disease	1.67e-05	0.000646	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TSHR—Graves' disease	1.53e-05	0.000592	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—B3GNT2—Graves' disease	1.47e-05	0.000572	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GC—Graves' disease	1.47e-05	0.000569	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-DQB1—Graves' disease	1.39e-05	0.000537	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IFNG—Graves' disease	1.3e-05	0.000505	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD8A—Graves' disease	1.29e-05	0.000502	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL2RA—Graves' disease	1.28e-05	0.000495	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CD4—Graves' disease	1.28e-05	0.000495	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD4—Graves' disease	1.26e-05	0.000487	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-B—Graves' disease	1.25e-05	0.000483	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD4—Graves' disease	1.23e-05	0.000475	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL2RA—Graves' disease	1.17e-05	0.000452	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL1B—Graves' disease	1.16e-05	0.00045	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-A—Graves' disease	1.15e-05	0.000447	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HLA-A—Graves' disease	1.13e-05	0.000438	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—B3GNT2—Graves' disease	1.11e-05	0.000431	CbGpPWpGaD
Docetaxel—EGFR—Disease—HLA-A—Graves' disease	1.07e-05	0.000413	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-DRB1—Graves' disease	1.05e-05	0.000409	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	1.05e-05	0.000405	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ICAM1—Graves' disease	1.01e-05	0.000392	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCL10—Graves' disease	9.87e-06	0.000383	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TNF—Graves' disease	9.69e-06	0.000375	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GC—Graves' disease	9.05e-06	0.000351	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IFNG—Graves' disease	7.7e-06	0.000298	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL2RA—Graves' disease	7.55e-06	0.000292	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD4—Graves' disease	7.44e-06	0.000288	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CD4—Graves' disease	7.28e-06	0.000282	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL1B—Graves' disease	6.87e-06	0.000266	CbGpPWpGaD
Docetaxel—EGFR—Disease—CD4—Graves' disease	6.87e-06	0.000266	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—B3GNT2—Graves' disease	6.86e-06	0.000266	CbGpPWpGaD
